Example: Heart Attack

Clinical Trials on Hypercoagulability

Total 20 results

NCT05540834

Recruiting

Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory Failure (VETtiPAT-ARF)

Acute Respiratory Failure | Hypercoagulability | Fibrinolysis Shutdown
NCT05376046

Recruiting

Study of Erythrocyte Parameters and Hypercoagulability in Sickle Cell Disease (SCD-TGA) (SCD-TGA)

Sickle Cell Disease | Vaso-occlusive Crisis
NCT04896203

Recruiting

Hypercoagulability Study Using Haemostatic Techniques in Patients With Inflammatory Bowel Disease (EDGAR)

Thrombosis | Inflammatory Bowel Diseases | Blood Coagulation Disorder
NCT03625726

Recruiting

Rôle of the Soluble Endothelial Protein C Receptor in Cirrhosis-associated Hypercoagulability State (EXERCISE) (EXERCISE)

Cirrhosis
NCT02726698

Active, not recruiting

Reappraisal of Atrial Fibrillation: Interaction Between HyperCoagulability, Electrical Remodeling, and Vascular Destabilisation in the Progression of Atrial Fibrillation (RACE V)

Atrial Fibrillation
NCT04503317

Completed

Effect of Phototherapy With Exercise on Coagulation in Elderly

Obesity | Hypercoagulability
NCT04059965

Withdrawn

AntiCoagulation Tracking InterVention and Evaluation (ACTIVE)

Stroke | Atrial Fibrillation | Deep Vein Thrombosis | Anticoagulation | Atrial Flutter | Pulmonary Embolus/Emboli | Hypercoagulability
NCT04736901

Completed

Effect of Prophylactic and Therapeutic Anticoagulants in Egyptian Patients With COVID-19

Covid19 | Corona Virus Infection | Hypercoagulability
NCT05012501

Completed

Analysis of Neutrophil Extracellular Traps in Hypercoagulability and Portal Vein Thrombosis in Liver Cirrhosis Patients

Liver Cirrhosis | Portal Vein Thrombosis | Neutrophil Extracellular Trap Formation
NCT04393805

Completed

Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto (HETHICO)

COVID-19 | Hypercoagulability
NCT04367662

Completed

Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19 (COVID'HEMOS)

COVID-19
NCT02701452

Terminated

Ovarian Hyperstimulation Syndrome in Patients Triggered by GnRH Agonist for Excessive Follicular Response (COAGO)

Ovarian Hyperstimulation Syndrome | Hypercoagulability
NCT02718924

Completed

Detecting Hypercoagulability in Morbidly Obese and Non Obese Parturients Following Cesarean Section Delivery

Obesity | Pregnancy | Hypercoagulability
NCT02862366

Completed

Role of the Circulating Procoagulants Microparticles in the Hypercoagulability of MNP Ph1- (MICROP-SMP)

Myeloproliferative Neoplasm
NCT03531437

Terminated

Comparison of Coagulation Profiles Between Zoely and Minidoz: RCT

Contraception | Hypercoagulability
NCT01799655

Completed

Does Vitamin D Deficiency Associated With Hypercoagulability & Increased Thrombin Generation?

Chest Pain
NCT01046942

Unknown

ThrombElastoGraphic Haemostatic Status and Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery (TEG-CABG)

Thrombosis | Coronary Artery Bypass Grafting Surgery | Hypercoagulability | Graft Patency
NCT00210197

Completed

Hypercoagulability After Breast Cancer Surgery (EHC)

Breast Cancer | Blood Coagulation Disorders
NCT00354796

Unknown

The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With Enoxaparin

Atrial Fibrillation | Acute Coronary Syndrome | Venous Thromboembolism | Hypercoagulability
NCT00400504

Unknown

Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®)

Cancer

Clinical Trials on Hypercoagulability

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations